Determination of Some Drugs in Blood Plasma Using Liquid Chromatography-MS

  • Qasim Mezban Salih College of Science, Wasit University, Wasit, Iraq
Keywords: spectrometry, febuxostat human plasma, bioequivalence, chromatography

Abstract

The accurate quantification regarding febuxostat levels in human plasma will be accomplished using a liquid chromatography - tandem mass spectrometry (LCESI-MS/MS) assay with a robust sensitivity, selectivity, and reliability. Indomethacin was used as the internal standard (IS) in the test. Using methyl tert-butyl ether as extraction solvent, the analyte as well as IS have been mined from 200μL human plasma sample using extraction procedure (liquid - liquid). A Hypurity C-18 column with particle size dimensions of 100mm x 4.6mm and a column with 5μm particle size were used in the experiment in order to perform the chromatography. Under isocratic circumstances, the chromatography has been performed. Tandem mass spectrometry, which could operate in a negative ionization reaction condition range and efficiently observe various reaction modes, has been used for the purpose of detecting the analyte and internal standard. The deprotonated precursor ions were represented by observed changes of product ions for the febuxostat and indomethacin, which have been m/z 356.10 → 312 and 315.10 → 271, respectively. This technique had demonstrated a 0.05μg/mL limit of quantitation and a 0.0025 μg/mL limit of detection. Validated linear dynamic range of febuxostat has been found to be 0.05g/mL–6g/mL. Precision, which is expressed as the coefficient of variation (% CV) within and across batches, has been determined to be ≤7.1%. It was revealed that average extraction recovery of the febuxostat at various levels of quality control has been >87%. In order to ascertain bio-equivalence of 80mg febuxostat tablet form in a group that includes 14 healthy males of origin, the current study successfully used the previously indicated methodology. The experiment was conducted under both fed and fasted circumstances. The potential for duplicating the measurements regarding study outcomes was shown by re-examining 110 incurred cases.

References

C. Han, C. B. Davis, and B. Wang, Eds., Evaluation of Drug Candidates for Preclinical Development: Pharmacokinetics, Metabolism, Pharmaceutics, and Toxicology, vol. 12. John Wiley & Sons, 2015.

S. Zhou, Q. Song, Y. Tang, and W. Naidong, "Critical Review of Development, Validation, and Transfer for High Throughput Bioanalytical LCMS/MS Methods," Current Pharmaceutical Analysis, vol. 1, no. 1, pp. 3-14, 2015.

N. R. Srinivas, "Applicability of Bioanalysis of Multiple Analytes in Drug Discovery and Development: Review of Select Case Studies Including Assay Development Considerations," Biomedical Chromatography, vol. 20, no. 5, pp. 383-414, 2016.

H. C. Liu, R. H. Liu, D. L. Lin, and H. O. Ho, "Rapid Screening and Confirmation of Drugs and Toxic Compounds in Biological Specimens Using Liquid Chromatography/Ion Trap Tandem Mass Spectrometry and Automated Library Search," Rapid Communications in Mass Spectrometry, vol. 24, no. 1, pp. 75-84, 2017.

R. Oertel, K. Richter, T. Gramatte, and W. Kirch, "Determination of Drugs in Biological Fluids by High-Performance Liquid Chromatography with On-Line Sample Processing," Journal of Chromatography A, vol. 797, no. 1, pp. 203-209, 2018.

B. K. Matuszewski, M. L. Constanzer, and C. M. Chavez-Eng, "Strategies for the Assessment of Matrix Effect in Quantitative Bioanalytical Methods Based on HPLC-MS/MS," Analytical Chemistry, vol. 75, no. 13, pp. 3019-3030, 2019.

M. Dole, L. L. Mack, R. L. Hines, R. C. Mobley, L. D. Ferguson, and M. D. Alice, "Molecular Beams of Macroions," The Journal of Chemical Physics, vol. 49, no. 5, pp. 2240-2249, 2015.

M. Yamashita and J. B. Fenn, "Electrospray Ion Source: Another Variation on the Free-Jet Theme," The Journal of Physical Chemistry, vol. 88, no. 20, pp. 4451-4459, 2016.

M. L. Aleksandrov, L. N. Gall, N. V. Krasnov, V. I. Nikolayev, V. A. Pavlenko, and V. A. Shkurov, "Extraction of Ions from Solutions at Atmospheric Pressure," Patel C.D. References K.B.I.P.E.R. Kadi Sarva Vishwavidyalaya, Gandhinagar, p. 433 of 450, 2017.

S. Zhou, Q. Song, Y. Tang, and W. Naidong, "Critical Review of Development, Validation, and Transfer for High Throughput Bioanalytical LCMS/MS Methods," Current Pharmaceutical Analysis, vol. 1, no. 1, pp. 3-14, 2015.

B. L. Ackermann, M. J. Berna, J. A. Eckstein, L. W. Ott, and A. K. Chaudhary, "Current Applications of Liquid Chromatography/Mass Spectrometry in Pharmaceutical Discovery After a Decade of Innovation," Annual Review of Analytical Chemistry, vol. 1, pp. 357-396, 2018.

D. B. Robb, T. R. Covey, and A. P. Bruins, "Atmospheric Pressure Photoionization: An Ionization Method for Liquid Chromatography-Mass Spectrometry," Analytical Chemistry, vol. 72, no. 15, pp. 3653-3659, 2020.

J. A. Syage and M. D. Evans, "Photoionization Mass Spectrometry: A Powerful New Tool for Drug Discovery," Spectroscopy-Eugene, vol. 16, no. 11, pp. 14-21, 2021.

I. N. Papadoyannis, HPLC in Clinical Chemistry, Dekker, 2020.

S. Quaranta, C. Woloch, A. Paccou, M. Giocanti, C. Solas, and B. Lacarelle, "Microdose Pharmacokinetics of IDX899 and IDX989, Candidate HIV1 Non-Nucleoside Reverse Transcriptase Inhibitors, Following Oral and Intravenous Administration in Healthy Male Subjects," The Journal of Clinical Pharmacology, vol. 49, no. 12, pp. 1408-1416, 2019.

H. C. Liu, R. H. Liu, D. L. Lin, and H. O. Ho, "Rapid Screening and Confirmation of Drugs and Toxic Compounds in Biological Specimens Using Liquid Chromatography/Ion Trap Tandem Mass Spectrometry and Automated Library Search," Rapid Communications in Mass Spectrometry, vol. 24, no. 1, pp. 75-84, 2020.

R. Oertel, K. Richter, T. Gramatte, and W. Kirch, "Determination of Drugs in Biological Fluids by High-Performance Liquid Chromatography with On-Line Sample Processing," Journal of Chromatography A, vol. 797, no. 1, pp. 203-209, 2021.

B. K. Matuszewski, M. L. Constanzer, and C. M. Chavez-Eng, "Strategies for the Assessment of Matrix Effect in Quantitative Bioanalytical Methods Based on HPLC-MS/MS," Analytical Chemistry, vol. 75, no. 13, pp. 3019-3030, 2019.

D. A. Wells, High Throughput Bioanalytical Sample Preparation: Methods and Automation Strategies, vol. 5, Elsevier Science, 2003.

J. M. Dethy, B. L. Ackermann, C. Delatour, J. D. Henion, and G. A. Schultz, "Demonstration of Direct Bioanalysis of Drugs in Plasma Using Nanoelectrospray Infusion from a Silicon Chip Coupled with Tandem Mass Spectrometry," Analytical Chemistry, vol. 75, no. 4, pp. 805-811, 2019.

L. Li, F. Liu, X. Kong, S. Su, and K. A. Li, "Investigation of a Liquid–Liquid Extraction System Based on Non-Ionic Surfactant–Salt–H2O and Mechanism of Drug Extraction," Analytica Chimica Acta, vol. 452, no. 2, pp. 321-328, 2022.

S. S. Sagdullaev, A. Z. Sadikov, T. T. Shakirov, and R. A. Rafikov, "Liquid-Liquid Extraction Technology for Production of the Antiarrhythmic Drug Aclezin from the Above-Ground Part of Aconitum Leucostomum," 2020.

M. E. Ernst and M. A. Fravel, "Febuxostat: A Selective Xanthine Oxidase/Xanthine Dehydrogenase Inhibitor for the Management of Hyperuricemia in Patients with Gout," Clinical Therapeutics, vol. 31, pp. 2503-2518, 2019.

Published
2024-07-23
How to Cite
Salih, Q. M. (2024). Determination of Some Drugs in Blood Plasma Using Liquid Chromatography-MS. Central Asian Journal of Medical and Natural Science, 5(4), 78-92. Retrieved from https://cajmns.centralasianstudies.org/index.php/CAJMNS/article/view/2525
Section
Articles